Media releases
16 June 2011
Novartis application for expanded Menveo® indication from 2 months of age accepted for review by FDA
09 June 2011
19 May 2011
Novartis welcomes endorsement of Pandemic Influenza Preparedness Framework at World Health Assembly
12 May 2011
Novartis vaccine Menveo® now supported by three years of immune persistence and safety data
22 March 2011
31 January 2011
Feature stories ›
Read in-depth stories about how Novartis is addressing the changing needs of patients and societies worldwide.
Fact sheet ›
Read and download the Novartis fact sheet.
Multimedia library ›
Visit the Novartis multimedia library to view and download photos, images and videos.
Media contacts ›
Novartis Vaccines welcomes enquiries from the media. If you don't find the information you need here, please feel free to contact us directly with any questions you may have.
Disease & products
Learn about meningitis, influenza, rabies, TBE and japanese encephalities.
About Novartis Vaccines
Novartis Vaccines is the world's fifth-largest vaccines business.
